title: [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
abstract: Polycystic ovary syndrome is a heterogeneous disorder characterized by chronic ovulatory dysfunction and hyperandrogenism. It occurs in 6-8% of the female population in the reproductive age. The syndrome may be associated with various metabolic disorders which may impair the quality of life and life expectancy of patients. The diagnosis in adults is usually established by the presence of three criteria. Polycystic ovary syndrome can be also identified in adolescent girls. Although the clinical, hormonal and metabolic features are similar to those found in adult women, it may be difficult to distinguish normal adolescents from those with polycystic ovary syndrome. Irregular menstruation, anovulatory cycles, and acne are not uncommon in adolescents, and polycystic ovary syndrome may mimic physiological anovulation in adolescents. There is a high probability of polycystic ovary syndrome if anovulatory cycles persist for more than 2 years. The diagnosis of polycystic ovary syndrome in adolescents may require a unique set of criteria, however, there are no generally accepted recommendations for the diagnostic work-up. The authors propose that hyperandrogenemia is often the most reliable finding in this age group, and it may be prudent to define adolescent polycystic ovary syndrome according to the Rotterdam consensus criteria. Obesity in adolescent girls may increase the severity of symptoms of polycystic ovary syndrome and this underlines the importance of early diagnosis and treatment.
authors: Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház Csecsemő- és Gyermekosztály Miskolc Pf. 188 3501 Miskolci Egyetem, Egészségügyi Kar Preventív Egészségtudományi Tanszék Miskolc. sagodilaszlo@gmail.com
authors: László
authors: L
authors: Ságodi
authors: László
authors: L
authors: Barkai
mesh_terms: D000293:Adolescent; D000328:Adult; D000858:Anovulation / Q000209:etiology* / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology* / Q000378:metabolism; D008599:Menstruation Disturbances / Q000209:etiology* / Q000378:metabolism; D009765:Obesity / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D011627:Puberty
chemical_list: D012739:Gonadal Steroid Hormones